Passività Correnti Cambiamento Data
Agenus USD 231.82M 17.42M 2026-06
Alaunos Therapeutics USD 864K 269K 2026-06
Amgen USD 23.23B 2.27B 2026-09
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 311.34M 27.99M 2026-09
AstraZeneca USD 31.27B 286M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Heron Therapeutics USD 89.85M 2.3M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Ligand Pharmaceuticals USD 500.57M 453.83M 2026-09
MacroGenics USD 107.23M 1.58M 2026-09
MannKind USD 108.52M 34.37M 2026-09
Merck USD 28.8B 1.07B 2026-09
Novartis USD 32.52B 777M 2026-09
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Thermo Fisher Scientific USD 14.17B 899M 2026-09
Veracyte USD 84.21M 21.47M 2026-09
Xencor USD 76.27M 5.6M 2026-09